The opiorphin analog STR-324 decreases sensory hypersensitivity in a rat model of neuropathic pain
A Van Elstraete, P Sitbon, L Hamdi… - Anesthesia & …, 2018 - journals.lww.com
BACKGROUND: Neuropathic pain represents a therapeutic challenge, and treatments with
increased efficacy and tolerability still need to be developed. Opiorphin protects …
increased efficacy and tolerability still need to be developed. Opiorphin protects …
The Opiorphin Analog STR-324 Decreases Sensory Hypersensitivity in a Rat Model of Neuropathic Pain.
A Van Elstraete, P Sitbon, L Hamdi… - Anesthesia and …, 2018 - europepmc.org
Background Neuropathic pain represents a therapeutic challenge, and treatments with
increased efficacy and tolerability still need to be developed. Opiorphin protects …
increased efficacy and tolerability still need to be developed. Opiorphin protects …
The Opiorphin Analog STR-324 Decreases Sensory Hypersensitivity in a Rat Model of Neuropathic Pain
A Van Elstraete, P Sitbon, L Hamdi… - Anesthesia and …, 2018 - pubmed.ncbi.nlm.nih.gov
Background Neuropathic pain represents a therapeutic challenge, and treatments with
increased efficacy and tolerability still need to be developed. Opiorphin protects …
increased efficacy and tolerability still need to be developed. Opiorphin protects …
[PDF][PDF] The Opiorphin Analog STR-324 Decreases Sensory Hypersensitivity in a Rat Model of Neuropathic Pain
MD Alain Van Elstraete, P Sitbon, L Hamdi… - 2017 - researchgate.net
BACKGROUND: Neuropathic pain represents a therapeutic challenge, and treatments with
increased efficacy and tolerability still need to be developed. Opiorphin protects …
increased efficacy and tolerability still need to be developed. Opiorphin protects …